INNVIERTE
The CDTI Innovation invests, together with SABADELL ASABYS HEALTH INNOVATION INVESTMENTS II, RCF and SABADELL ASABYS HEALTH INNOVATION INVESTMENTS 2B, SCR SA, QUIBIM, S.L., company biomedical technology
The input committed by the CDTI innovation is eur 2,500,000
Ver sección
El CDTI Innovación invierte en la empresa estratégica ONCOMATRYX BIOPHARMA S.L., pionera en el desarrollo de fármacos contra el microambiente tumoral
The input committed by the CDTI innovation is eur 10,000,000
Ver sección
El CDTI Innovación invierte, junto con INVEREADY BIOTECH IV S.C.R, S.A, INVEREADY BIOTECH IV PARELLEL S.C.R., S.A, e INVEREADY INNVIERTE CONVERTIBLE TECH NOTES I S.C.R, S.A., en GENIOVA TECHNOLOGIES S.L
The input committed by the CDTI innovation is eur 3.6 million
Ver sección
The CDTI invests, together with NARA CAPITAL, in Tesai Care SL, medical devices to prevent and treat respiratory muscle atrophy electrostimulation with non-invasive
The input committed by the CDTI innovation is €270,000
Ver sección
The CDTI invests together with Ysios Capital and Asabys Partners in Anaconda Biomed, medical devices company neurovasculares
The input committed by the CDTI Innovation is eur 3.6 million
Ver sección
Innvierte allocates more than 350 million euros in October and November to eight new co-investments in venture capital and five investment vehicles.
Estas operaciones, realizadas en EBTs o innovadoras, están destinadas a diversos desarrollos de los sectores Generalista, Bio, Salud y Agroalimentación, TIC, Industria, Energía y Medioambiente
Ver sección
The CDTI commits more than 1,000 million euros in venture capital funds and co-investments through Innvierte.
En el segundo semestre del año, Innvierte adquiere compromisos en 17 fondos de capital riesgo y ha aprobado 28 nuevas coinversiones, dos de ellas estratégicas
Ver sección
CDTI Innovation invests, together with GPC, in TEBRIO, a biotechnology company in the insect protein sector. 
La aportación comprometida por el CDTI Innovación es de 6.931.000 euros
Ver sección
CDTI Innovation invests, together with INVEREADY FIRST CAPITAL III PARALLEL, F.C.R. and INVEREADY FIRST CAPITAL III S.C.R.E., S.A., in UNION AVATARS, a company developing an avatar creation platform.
The input committed by the CDTI innovation is eur 328
Ver sección
Subscribe to INNVIERTE